Skip to content

What does FRAX do? Understanding the Fracture Risk Assessment Tool

3 min read

Approximately one in two women and up to one in four men age 50 and older will break a bone due to osteoporosis in their lifetime. Healthcare professionals utilize the FRAX tool, which estimates an individual’s fracture probability, to help manage this risk.

Quick Summary

The FRAX tool calculates a patient's 10-year probability of a major osteoporotic or hip fracture based on several clinical risk factors.

Key Points

  • Purpose: FRAX estimates a patient's 10-year probability of suffering a major osteoporotic or hip fracture.

  • Inputs: The calculation uses several clinical risk factors, including age, sex, BMI, and lifestyle choices, and can also incorporate femoral neck BMD.

  • Application: It is used by clinicians to identify patients with low bone mass (osteopenia) who are at high risk and may require treatment.

  • Limitations: The tool has limitations, such as using binary inputs for dose-dependent factors and not including fall history.

  • Target Population: It is primarily intended for use in postmenopausal women or men over 50 who have not yet started osteoporosis treatment.

  • Clinical Guidance: Results help guide treatment decisions and discussions about medication, lifestyle changes, and fall prevention.

  • Future Development: A more advanced version, FRAXplus, is in development to address some of the tool's current limitations.

In This Article

What Is the FRAX Tool?

Developed by the World Health Organization (WHO), the FRAX tool is a free, web-based tool used globally to estimate a patient's 10-year risk of a major osteoporotic or hip fracture. It provides a more comprehensive assessment by integrating various clinical risk factors instead of relying solely on bone mineral density (BMD) test results. FRAX helps identify patients with low bone mass (osteopenia) who are at high risk for fracture and guides clinicians in determining who might benefit from further evaluation or treatment. The tool is widely available online and incorporated into clinical guidelines.

How Does FRAX Calculate Your Risk?

The FRAX tool calculates fracture risk using country-specific algorithms based on several input factors. These include patient demographics like age, sex, weight, and height, a history of prior fragility fracture, parental history of hip fracture, lifestyle factors such as smoking and alcohol consumption, medical conditions like rheumatoid arthritis, and long-term oral use of glucocorticoids. Including femoral neck DEXA results is optional but recommended to refine the calculation.

Interpreting Your FRAX Results

FRAX provides the 10-year probability of a major osteoporotic fracture and the 10-year probability of a hip fracture. These scores are used with national guidelines to inform treatment decisions. For instance, in the US, specific thresholds for hip fracture (3% or higher) or major osteoporotic fracture (20% or higher) probability may indicate the need for pharmacological treatment. Lower scores might suggest that lifestyle changes and monitoring are sufficient.

How Healthcare Providers Use FRAX for Treatment Decisions

FRAX assists healthcare providers in discussing bone health with patients by:

  1. Risk Stratification: Identifying high-risk individuals with osteopenia who may benefit from treatment.
  2. Targeted Intervention: Guiding therapeutic choices based on absolute fracture risk.
  3. Shared Decision-Making: Providing a quantitative risk estimate for informed patient decisions.
  4. Cost-Effectiveness: Helping to prioritize pharmacological intervention for those most likely to benefit.

Limitations of the FRAX Tool

FRAX has limitations that require clinical consideration:

  • Binary Inputs: Uses simple 'yes/no' for factors like prior fractures or glucocorticoid use, not accounting for severity or dose.
  • Exclusion of Falls: Does not include fall history, a significant fracture risk factor.
  • BMD Site Limitations: Only uses femoral neck BMD, which may not capture risk accurately in all cases.
  • Untreated Patients Only: Intended for patients not currently on osteoporosis treatment.

Comparison of BMD and FRAX Assessment

Feature Bone Mineral Density (BMD) Test FRAX Tool
Focus Measures bone density at a specific site Estimates 10-year fracture probability using multiple factors
Output A T-score and Z-score Percentage probabilities for major osteoporotic and hip fractures
Factors Only measures bone density; doesn't incorporate clinical risk factors directly Integrates BMD (optional) with clinical risk factors like age, sex, and lifestyle
Application Diagnosing osteoporosis or osteopenia Predicting fracture risk and guiding treatment for those with low bone mass
Limitations Low sensitivity, as many fractures occur in people with osteopenia Simplistic inputs for some factors; doesn't account for falls

The Evolution of Fracture Risk Assessment

Ongoing research aims to improve fracture risk assessment. A developing version, FRAXplus, is intended to include more detailed information, such as dose-response relationships for glucocorticoids and a history of falls, for more accurate risk prediction.

Conclusion

FRAX provides a valuable and validated method for assessing an individual's 10-year fracture risk by combining clinical factors with or without BMD data. While not without limitations, it has significantly advanced the management of patients at risk for osteoporosis-related fractures, supporting crucial decisions to prevent serious injuries. The tool is an important aid for informed decision-making. More information and access to the tool can be found on {Link: FRAX website https://frax.shef.ac.uk/FRAX/}.

Frequently Asked Questions

A major osteoporotic fracture, as defined by FRAX, is a broken bone that occurs in the hip, clinical spine, forearm, or humerus (upper arm) as a result of low bone mass or osteoporosis.

A FRAX assessment is generally recommended for postmenopausal women and men aged 50 and older who have low bone mass (osteopenia) and are not currently on osteoporosis medication. It helps clinicians and patients make informed decisions about bone health.

No, the FRAX tool was not developed for and should not be used to monitor the effectiveness of osteoporosis therapy. It is intended for assessing risk in treatment-naive individuals.

The standard FRAX tool has a binary 'yes/no' input for prior fracture history and does not account for the number or recency of fractures. This is a known limitation that requires clinical judgment. FRAXplus, a newer version, aims to address this.

When the FRAX model was developed, the methodology for incorporating fall risk was not standardized. Since then, it has been recognized as a significant limitation, and researchers recommend that clinicians consider fall risk separately during their assessment. The new FRAXplus tool is designed to include a fall history input.

Yes, FRAX models are calibrated to reflect the specific epidemiology of fracture and mortality rates in different countries and geographic regions. When using the tool online, you must select the model for your specific country.

A high FRAX score means you have an increased probability of fracture and should have a conversation with your healthcare provider. Your doctor will discuss the results with you and determine the most appropriate course of action, which may include medication, lifestyle changes, or a fall prevention plan.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.